UiPath, Inc. $PATH Position Boosted by Invenomic Capital Management LP

Key Points

• Invenomic Capital Management LP increased its stake in UiPath, Inc. by 46.8% in the first quarter, owning a total of 528,839 shares valued at approximately $5.4 million.
• Several other institutional investors also raised their stakes, with Versant Capital Management increasing its holdings by 198.6% and Brooklyn Investment Group by 314.3% in the same period.
• Analysts have mixed opinions on UiPath, with a consensus rating of "Hold", price targets ranging from $12.00 to $16.00, and a recent EPS of $0.15, exceeding estimates by $0.07.

Invenomic Capital Management LP lifted its position in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 46.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 528,839 shares of the company's stock after acquiring an additional 168,690 shares during the period. Invenomic Capital Management LP owned about 0.10% of UiPath worth $5,447,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of UiPath by 3.0% during the 1st quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company's stock valued at $495,029,000 after acquiring an additional 1,396,972 shares in the last quarter. Federated Hermes Inc. raised its position in shares of UiPath by 479.3% during the 1st quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company's stock valued at $58,917,000 after acquiring an additional 4,732,712 shares in the last quarter. Jacobs Levy Equity Management Inc. raised its position in shares of UiPath by 35.6% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock valued at $69,385,000 after acquiring an additional 1,432,569 shares in the last quarter. Two Sigma Investments LP raised its position in shares of UiPath by 8.2% during the 4th quarter. Two Sigma Investments LP now owns 5,276,248 shares of the company's stock valued at $67,061,000 after acquiring an additional 400,726 shares in the last quarter. Finally, Two Sigma Advisers LP raised its position in shares of UiPath by 29.0% during the 4th quarter. Two Sigma Advisers LP now owns 4,901,000 shares of the company's stock valued at $62,292,000 after acquiring an additional 1,100,800 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 56,322 shares of the firm's stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $12.72, for a total transaction of $716,415.84. Following the transaction, the chief financial officer directly owned 859,991 shares of the company's stock, valued at approximately $10,939,085.52. This trade represents a 6.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $12.43, for a total value of $559,350.00. Following the transaction, the chief executive officer directly owned 5,058,376 shares of the company's stock, valued at $62,875,613.68. This represents a 0.88% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 831,310 shares of company stock worth $10,428,922 over the last three months. Corporate insiders own 23.19% of the company's stock.

UiPath Stock Up 2.7%

NYSE PATH traded up $0.31 during trading hours on Monday, hitting $11.80. The company had a trading volume of 15,988,423 shares, compared to its average volume of 11,748,976. UiPath, Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $15.93. The business has a fifty day simple moving average of $11.74 and a 200-day simple moving average of $11.79. The firm has a market cap of $6.31 billion, a P/E ratio of 393.27, a price-to-earnings-growth ratio of 12.07 and a beta of 1.02.

UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.07. The firm had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. UiPath had a return on equity of 1.27% and a net margin of 1.35%.The firm's revenue for the quarter was up 14.6% on a year-over-year basis. During the same period last year, the company earned $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Equities analysts forecast that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. DA Davidson assumed coverage on UiPath in a research report on Friday. They set a "neutral" rating and a $12.00 price target on the stock. Royal Bank Of Canada upped their price target on UiPath from $13.00 to $15.00 and gave the company a "sector perform" rating in a research report on Friday, May 30th. Evercore ISI increased their target price on UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a research report on Friday, May 30th. Wall Street Zen raised UiPath from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Finally, Zacks Research raised UiPath to a "hold" rating in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $13.18.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.